Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational p...
Leadership
Grant E. Pickering M.B.A.Founder
Co-Founder, CEO & Director
Andrew L. Guggenhime M.B.A.
President & CFO
James T. Wassil M.B.A., M.S.
Executive VP & COO
Mikhail Eydelman J.D.
Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
